NVIV - InVivo Therapeutics Holdings Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts1111
Avg. Estimate-5.4-5.7-21.9-10.8
Low Estimate-5.4-5.7-21.9-10.8
High Estimate-5.4-5.7-21.9-10.8
Year Ago EPS-8.4-10.2-35.28-21.9
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts1111
Avg. EstimateN/AN/AN/A400k
Low EstimateN/AN/AN/A400k
High EstimateN/AN/AN/A400k
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History3/30/20196/29/20199/29/201912/30/2019
EPS Est.-8.7-9.3-9.9-9
EPS Actual-8.4-10.2-8.7-7.98
Difference0.3-0.91.21.02
Surprise %3.40%-9.70%12.10%11.30%
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate-5.4-5.7-21.9-10.8
7 Days Ago-5.4-5.7-21.9-10.8
30 Days Ago-5.4-5.7-21.9-10.8
60 Days Ago-0.18-0.19-0.73-0.36
90 Days Ago-0.18-0.19-0.73-0.36
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNVIVIndustrySectorS&P 500
Current Qtr.35.70%N/AN/A-0.06
Next Qtr.44.10%N/AN/A-0.05
Current Year37.90%N/AN/A-0.06
Next Year50.70%N/AN/A0.18
Next 5 Years (per annum)N/AN/AN/A0.06
Past 5 Years (per annum)N/AN/AN/AN/A